Figma and Anthropic are partnering on AI coding tools that integrate Claude Code. Software stocks have sold off as AI tools threaten to upend the industry. Figma reports earnings Wednesday. The stock ...

Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. is a senior editor and author of Notepad, ...

Starbucks is rolling out a new seasonal menu update, with fresh beverages and snacks to enjoy at the coffee giant. Global chief brand officer Tressie Lieberman said the new menu is all about ...

Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...

WEST PHILADELPHIA (WPVI) -- Business and life partners Sasha Vivek and Britt Gilbert recently opened a unique space in West Philadelphia offering light bites and authentic chai. The cafe aspect of ...

It’s the moment software engineers, executives and investors turn their work over to Anthropic’s Claude AI—and then witness a thinking machine of shocking capability, even in an age awash in powerful ...

Cowork is a user-friendly version of Anthropic’s Claude Code AI-powered tool that’s built for file management and basic computing tasks. Here’s what it's like to use it. This poor track record makes ...

Chai Discovery’s AI platform, including purpose-built custom models, will be deployed to accelerate the discovery of next-generation therapeutics SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI ...

When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules. The deal, which values the company ...